Thrombocytopenia among people living with HIV: prevalence, associated factors, and secondary causes in a tertiary-care cohort
Journal of Health Sciences and Medicine · 25.10.2026 · 9 (6) · 1669-1674
DOI: 10.32322/jhsm.2019327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Health Sciences and Medicine, online erschienen am 25.10.2026. Verfasst von Semanur Kuzi und 3 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Gefördert von: No financial support was received for this study..
Abstract (Originalsprache)
Aims
To determine the prevalence and severity of thrombocytopenia among people living with HIV (PLWH), identify associated factors, and assess whether HIV-related associations persist after exclusion of major secondary causes.
Methods
This retrospective study included adults with HIV followed at a tertiary-care center between January 2023 and July 2024. Baseline laboratory parameters obtained before initiation of antiretroviral therapy were used. Thrombocytopenia was defined as platelet count
Förderung
- No financial support was received for this study.
Zitieren
APA
Kuzi, S., Korkmaz, N., Bulut, D., & Şentürk, G. Ç. (2026). Thrombocytopenia among people living with HIV: prevalence, associated factors, and secondary causes in a tertiary-care cohort. Journal of Health Sciences and Medicine, 9(6), 1669-1674. https://doi.org/10.32322/jhsm.2019327
Vancouver
Kuzi S, Korkmaz N, Bulut D, Şentürk GÇ. Thrombocytopenia among people living with HIV: prevalence, associated factors, and secondary causes in a tertiary-care cohort. Journal of Health Sciences and Medicine. 2026;9(6):1669-1674. doi:10.32322/jhsm.2019327
BibTeX
@article{Kuzi2026,
author = {Kuzi, Semanur and Korkmaz, Nesibe and Bulut, Dilek and Şentürk, Gönül Çiçek},
title = {Thrombocytopenia among people living with HIV: prevalence, associated factors, and secondary causes in a tertiary-care cohort},
journal = {Journal of Health Sciences and Medicine},
year = {2026},
volume = {9},
number = {6},
pages = {1669--1674},
doi = {10.32322/jhsm.2019327}
}
EUVIMED